Dehydrodieugenol improved lung inflammation in an asthma model by inhibiting the STAT3/SOCS3 and MAPK pathways.
- DOI
- 10.1016/j.bcp.2020.114175
- Published
- 2020 Oct
- Container
- Biochemical pharmacology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bcp.2020.114175,
title = {Dehydrodieugenol improved lung inflammation in an asthma model by inhibiting the STAT3/SOCS3 and MAPK pathways.},
author = {Santana FPR and da Silva RC and Ponci V and Pinheiro AJMCR and Olivo CR and Caperuto LC and Arantes-Costa FM and Claudio SR and Ribeiro DA and Tibério IFLC and Lima-Neto LG and Lago JHG and Prado CM},
year = {2020},
journal = {Biochemical pharmacology},
doi = {10.1016/j.bcp.2020.114175},
url = {https://doi.org/10.1016/j.bcp.2020.114175}
}RIS
TY - JOUR TI - Dehydrodieugenol improved lung inflammation in an asthma model by inhibiting the STAT3/SOCS3 and MAPK pathways. AU - Santana FPR AU - da Silva RC AU - Ponci V AU - Pinheiro AJMCR AU - Olivo CR AU - Caperuto LC AU - Arantes-Costa FM AU - Claudio SR AU - Ribeiro DA AU - Tibério IFLC AU - Lima-Neto LG AU - Lago JHG AU - Prado CM PY - 2020 JO - Biochemical pharmacology DO - 10.1016/j.bcp.2020.114175 UR - https://doi.org/10.1016/j.bcp.2020.114175 ER -
APA
FPR, S., RC, D. S., V, P., AJMCR, P., CR, O., LC, C., FM, A., SR, C., DA, R., IFLC, T., LG, L., JHG, L., & CM, P. (2020). Dehydrodieugenol improved lung inflammation in an asthma model by inhibiting the STAT3/SOCS3 and MAPK pathways.. Biochemical pharmacology. https://doi.org/10.1016/j.bcp.2020.114175
Source records
- pubmed · retrieved 2026-09-27T16:46:54.563Z